431 related articles for article (PubMed ID: 6223078)
1. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
2. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
3. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
Melamed J; Arnaout MA; Colten HR
J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
[TBL] [Abstract][Full Text] [Related]
4. Complement-dependent histaminase release from human granulocytes.
Herman JJ; Rosner IK; Davis AE; Zeiger RS; Arnaout MA; Colten HR
J Clin Invest; 1979 Jun; 63(6):1195-202. PubMed ID: 109469
[TBL] [Abstract][Full Text] [Related]
5. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
6. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR
J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946
[TBL] [Abstract][Full Text] [Related]
9. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
[TBL] [Abstract][Full Text] [Related]
10. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
11. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
12. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
13. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
Krettli AU; Pontes de Carvalho LC
Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of membrane-associated complement receptor CR1.
Iida K; Nussenzweig V
J Immunol; 1983 Apr; 130(4):1876-80. PubMed ID: 6220069
[TBL] [Abstract][Full Text] [Related]
15. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
Ross GD; Cain JA; Lachmann PJ
J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
[TBL] [Abstract][Full Text] [Related]
16. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
Arnaout MA; Melamed J; Tack BF; Colten HR
J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).
Gaither TA; Hammer CH; Gadek JE; Katusha K; Santaella M; Frank MM
Mol Immunol; 1983 Jun; 20(6):623-35. PubMed ID: 6603572
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
Forslid J; Hed J; Stendahl O
Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
[TBL] [Abstract][Full Text] [Related]
20. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
Fries LF; Prince GM; Gaither TA; Frank MM
J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
